JP2006516568A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2006516568A5 JP2006516568A5 JP2006500781A JP2006500781A JP2006516568A5 JP 2006516568 A5 JP2006516568 A5 JP 2006516568A5 JP 2006500781 A JP2006500781 A JP 2006500781A JP 2006500781 A JP2006500781 A JP 2006500781A JP 2006516568 A5 JP2006516568 A5 JP 2006516568A5
- Authority
- JP
- Japan
- Prior art keywords
- composition
- days
- age
- phospholipid
- vitamin
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000000203 mixture Substances 0.000 claims 43
- 241000287828 Gallus gallus Species 0.000 claims 12
- 150000003904 phospholipids Chemical class 0.000 claims 11
- 210000001161 mammalian embryo Anatomy 0.000 claims 8
- GVJHHUAWPYXKBD-UHFFFAOYSA-N (±)-α-Tocopherol Chemical compound OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 claims 6
- HQKMJHAJHXVSDF-UHFFFAOYSA-L magnesium stearate Chemical compound [Mg+2].CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O HQKMJHAJHXVSDF-UHFFFAOYSA-L 0.000 claims 6
- 208000020016 psychiatric disease Diseases 0.000 claims 5
- 210000002257 embryonic structure Anatomy 0.000 claims 4
- 238000000034 method Methods 0.000 claims 4
- 208000024335 physical disease Diseases 0.000 claims 4
- AGPKZVBTJJNPAG-WHFBIAKZSA-N L-isoleucine Chemical compound CC[C@H](C)[C@H](N)C(O)=O AGPKZVBTJJNPAG-WHFBIAKZSA-N 0.000 claims 3
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 claims 3
- 229930003427 Vitamin E Natural products 0.000 claims 3
- 229940024606 amino acid Drugs 0.000 claims 3
- 235000001014 amino acid Nutrition 0.000 claims 3
- 150000001413 amino acids Chemical class 0.000 claims 3
- 239000003963 antioxidant agent Substances 0.000 claims 3
- 230000003078 antioxidant effect Effects 0.000 claims 3
- 235000006708 antioxidants Nutrition 0.000 claims 3
- 229920002678 cellulose Polymers 0.000 claims 3
- 239000001913 cellulose Substances 0.000 claims 3
- WIGCFUFOHFEKBI-UHFFFAOYSA-N gamma-tocopherol Natural products CC(C)CCCC(C)CCCC(C)CCCC1CCC2C(C)C(O)C(C)C(C)C2O1 WIGCFUFOHFEKBI-UHFFFAOYSA-N 0.000 claims 3
- 150000004676 glycans Chemical class 0.000 claims 3
- 229960000310 isoleucine Drugs 0.000 claims 3
- AGPKZVBTJJNPAG-UHFFFAOYSA-N isoleucine Natural products CCC(C)C(N)C(O)=O AGPKZVBTJJNPAG-UHFFFAOYSA-N 0.000 claims 3
- 239000008101 lactose Substances 0.000 claims 3
- 235000019359 magnesium stearate Nutrition 0.000 claims 3
- 229920001282 polysaccharide Polymers 0.000 claims 3
- 239000005017 polysaccharide Substances 0.000 claims 3
- 235000019165 vitamin E Nutrition 0.000 claims 3
- 229940046009 vitamin E Drugs 0.000 claims 3
- 239000011709 vitamin E Substances 0.000 claims 3
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 claims 2
- QAQJMLQRFWZOBN-LAUBAEHRSA-N L-ascorbyl-6-palmitate Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@H](O)[C@H]1OC(=O)C(O)=C1O QAQJMLQRFWZOBN-LAUBAEHRSA-N 0.000 claims 2
- 239000011786 L-ascorbyl-6-palmitate Substances 0.000 claims 2
- 235000010385 ascorbyl palmitate Nutrition 0.000 claims 2
- 238000011534 incubation Methods 0.000 claims 2
- 150000002632 lipids Chemical class 0.000 claims 2
- 239000007788 liquid Substances 0.000 claims 2
- 229940041678 oral spray Drugs 0.000 claims 2
- 239000000668 oral spray Substances 0.000 claims 2
- 230000002265 prevention Effects 0.000 claims 2
- GUBGYTABKSRVRQ-XLOQQCSPSA-N Alpha-Lactose Chemical compound O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@@H](CO)O[C@H](O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-XLOQQCSPSA-N 0.000 claims 1
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 claims 1
- 229930091371 Fructose Natural products 0.000 claims 1
- RFSUNEUAIZKAJO-ARQDHWQXSA-N Fructose Chemical compound OC[C@H]1O[C@](O)(CO)[C@@H](O)[C@@H]1O RFSUNEUAIZKAJO-ARQDHWQXSA-N 0.000 claims 1
- 239000005715 Fructose Substances 0.000 claims 1
- XUJNEKJLAYXESH-REOHCLBHSA-N L-Cysteine Chemical compound SC[C@H](N)C(O)=O XUJNEKJLAYXESH-REOHCLBHSA-N 0.000 claims 1
- ROHFNLRQFUQHCH-YFKPBYRVSA-N L-leucine Chemical compound CC(C)C[C@H](N)C(O)=O ROHFNLRQFUQHCH-YFKPBYRVSA-N 0.000 claims 1
- KDXKERNSBIXSRK-YFKPBYRVSA-N L-lysine Chemical compound NCCCC[C@H](N)C(O)=O KDXKERNSBIXSRK-YFKPBYRVSA-N 0.000 claims 1
- ROHFNLRQFUQHCH-UHFFFAOYSA-N Leucine Natural products CC(C)CC(N)C(O)=O ROHFNLRQFUQHCH-UHFFFAOYSA-N 0.000 claims 1
- KDXKERNSBIXSRK-UHFFFAOYSA-N Lysine Natural products NCCCCC(N)C(O)=O KDXKERNSBIXSRK-UHFFFAOYSA-N 0.000 claims 1
- 239000004472 Lysine Substances 0.000 claims 1
- 229930003268 Vitamin C Natural products 0.000 claims 1
- CJZGTCYPCWQAJB-UHFFFAOYSA-L calcium stearate Chemical compound [Ca+2].CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O CJZGTCYPCWQAJB-UHFFFAOYSA-L 0.000 claims 1
- 235000013539 calcium stearate Nutrition 0.000 claims 1
- 239000008116 calcium stearate Substances 0.000 claims 1
- 210000003837 chick embryo Anatomy 0.000 claims 1
- 235000018417 cysteine Nutrition 0.000 claims 1
- XUJNEKJLAYXESH-UHFFFAOYSA-N cysteine Natural products SCC(N)C(O)=O XUJNEKJLAYXESH-UHFFFAOYSA-N 0.000 claims 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 claims 1
- 208000035475 disorder Diseases 0.000 claims 1
- 238000000605 extraction Methods 0.000 claims 1
- 239000000796 flavoring agent Substances 0.000 claims 1
- 235000013355 food flavoring agent Nutrition 0.000 claims 1
- 230000037406 food intake Effects 0.000 claims 1
- -1 stearate compound Chemical class 0.000 claims 1
- 239000000126 substance Substances 0.000 claims 1
- 235000019154 vitamin C Nutrition 0.000 claims 1
- 239000011718 vitamin C Substances 0.000 claims 1
- 150000003700 vitamin C derivatives Chemical class 0.000 claims 1
- 150000003712 vitamin E derivatives Chemical class 0.000 claims 1
- XOOUIPVCVHRTMJ-UHFFFAOYSA-L zinc stearate Chemical compound [Zn+2].CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O XOOUIPVCVHRTMJ-UHFFFAOYSA-L 0.000 claims 1
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US10/336,150 US7033612B2 (en) | 2003-01-03 | 2003-01-03 | Composition and method for treating age-related disorders |
| PCT/US2004/000086 WO2004062626A2 (en) | 2003-01-03 | 2004-01-02 | Composition and method for treating age-related disorders |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2006516568A JP2006516568A (ja) | 2006-07-06 |
| JP2006516568A5 true JP2006516568A5 (https=) | 2007-02-22 |
Family
ID=32680944
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2006500781A Pending JP2006516568A (ja) | 2003-01-03 | 2004-01-02 | 加齢関連性障害を処置するための組成物および方法 |
Country Status (6)
| Country | Link |
|---|---|
| US (1) | US7033612B2 (https=) |
| EP (1) | EP1594473A4 (https=) |
| JP (1) | JP2006516568A (https=) |
| KR (1) | KR20050088153A (https=) |
| CN (1) | CN100430046C (https=) |
| WO (1) | WO2004062626A2 (https=) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2940116B1 (fr) * | 2008-12-22 | 2012-07-06 | Philippe Perovitch | Formulation pour l'administration d'hypolipemiant par voie trans-muqueuse buccale |
| KR20120114335A (ko) * | 2010-01-06 | 2012-10-16 | 마루다이 푸드 가부시키가이샤 | 뇌신경 세포 신생제 |
| CN102753183A (zh) * | 2010-02-03 | 2012-10-24 | 花王株式会社 | 运动功能改善剂 |
| WO2012090625A1 (ja) * | 2010-12-28 | 2012-07-05 | 医療法人社団ブックス | 認知症を血液サンプルで判定するための検査方法 |
| US20230248628A1 (en) * | 2020-06-30 | 2023-08-10 | Institute Of Rheological Function Of Food Co., Ltd. | Composition for hair growth and/or hair restoration |
| JP7162803B2 (ja) * | 2020-06-30 | 2022-10-31 | 株式会社 レオロジー機能食品研究所 | 発毛及び／又は育毛用組成物 |
Family Cites Families (16)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5801200A (en) * | 1984-03-19 | 1998-09-01 | The Picower Institute For Medical Research | Methods and materials for the diagnosis and treatment of conditions such as stroke |
| US5869534A (en) * | 1992-05-21 | 1999-02-09 | The Picower Institute For Medical Research | Glycosylation of lipids and lipid-containing particles, and diagnostic and therapeutic methods and materials derived therefrom |
| GB9000309D0 (en) | 1990-01-06 | 1990-03-07 | West Of Scotland College The | Method of producing a fatty acid |
| US5484611A (en) | 1992-07-15 | 1996-01-16 | The Scottish Agricultural College | Method of producing a fatty acid |
| FR2721481B1 (fr) * | 1994-06-27 | 1996-09-06 | Inst Rech Biolog Sa | Nouvelles compositions diététiques à base de phospholipides et leur utilisation comme complément nutritionnel. |
| US5696135A (en) * | 1995-06-07 | 1997-12-09 | Gpi Nil Holdings, Inc. | Inhibitors of rotamase enzyme activity effective at stimulating neuronal growth |
| CN1128144A (zh) * | 1995-07-13 | 1996-08-07 | 来风战 | 鸡胎精口服液 |
| US6383810B2 (en) * | 1997-02-14 | 2002-05-07 | Invitrogen Corporation | Dry powder cells and cell culture reagents and methods of production thereof |
| CN1194110A (zh) * | 1997-03-25 | 1998-09-30 | 高尔丰 | 鸡胚素及其加工方法 |
| FR2762993B1 (fr) * | 1997-05-06 | 1999-08-13 | Inst Rech Biolog Sa | Nouvelle utilisation de phospholipides d'origine animale en therapeutique et/ou dietetique |
| DE69906345T2 (de) * | 1998-10-30 | 2004-02-12 | Merck Patent Gmbh | Zusammensetzung zur behandlung und prävention neurologischer und pathopsychologischer krankheiten |
| CN1228963A (zh) * | 1998-12-28 | 1999-09-22 | 卢杲 | 一种治疗老年性痴呆症、帕金森症、心脑血管病的药物 |
| JP2001302521A (ja) * | 2000-04-24 | 2001-10-31 | Yasutaka Sakamoto | 鳥類胚抽出物を人体に応用するビジネスモデル |
| US6300377B1 (en) | 2001-02-22 | 2001-10-09 | Raj K. Chopra | Coenzyme Q products exhibiting high dissolution qualities |
| DK1417211T3 (da) * | 2001-07-27 | 2007-10-08 | Neptune Technologies & Bioress | Naturlige phospholipider af marin oprindelse, der indeholder flavonoider og polyumættede phospholipider, og deres anvendelse |
| KR100680121B1 (ko) * | 2001-08-09 | 2007-02-07 | 데구사 푸드 인그리디언츠 게엠베하 | (리소-)포스파티딜세린을 포함하는 온혈동물에서 스트레스상태의 예방 및 치료용 제제 |
-
2003
- 2003-01-03 US US10/336,150 patent/US7033612B2/en not_active Expired - Fee Related
-
2004
- 2004-01-02 WO PCT/US2004/000086 patent/WO2004062626A2/en not_active Ceased
- 2004-01-02 EP EP04700063A patent/EP1594473A4/en not_active Withdrawn
- 2004-01-02 JP JP2006500781A patent/JP2006516568A/ja active Pending
- 2004-01-02 CN CNB2004800058505A patent/CN100430046C/zh not_active Expired - Fee Related
- 2004-01-02 KR KR1020057012527A patent/KR20050088153A/ko not_active Ceased
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| BRPI0610180A2 (pt) | métodos para prevenir, para tratar, e para tratar ou controlar uma condição associada à inflamação | |
| US12390470B2 (en) | 1-methylxanthine-based bioactive composition and method of use thereof | |
| AU2022319030A1 (en) | Paraxanthine-based caffeine substitute compositions and method of use thereof in slow caffeine metabolizers | |
| TWI660726B (zh) | 預防頭痛的組成物 | |
| JP7352623B2 (ja) | 抗うつ製品の製造におけるヒドロキシチロソールおよびその誘導体の新規使用 | |
| ES2851525T3 (es) | Composiciones que comprenden 15(S)-HEPE para su uso en la sensibilización de las células cancerosas a la radioterapia | |
| CA2711673A1 (en) | Pharmaceutical compositions for treating fatty liver disease | |
| JP2006516568A5 (https=) | ||
| CN108135956A (zh) | 视神经保护用组合物 | |
| CA2549443A1 (en) | Diet supplements for causing fast weight loss, improving daytime energy, promoting nighttime relaxation and sleep, controlling appetite and/or increasing metabolism | |
| TW200816983A (en) | Anthracenedione compounds | |
| Liu et al. | Antioxidative effects of tetramethylpyrazine on acute ethanol-induced lipid peroxidation | |
| PT2011494E (pt) | Agente para melhoria de disfagia e composição farmacêutica ou alimentar compreendendo o mesmo | |
| CA3014239A1 (en) | Method and system for the treatment of medical conditions by intravenous therapy | |
| WO2008013215A1 (fr) | Préparation orale induisant le sommeil, et préparation orale pour soigner l'insomnie liée au stress | |
| KR20220123272A (ko) | 인지 장애 치료용 조성물 | |
| CN100430046C (zh) | 用于治疗与年龄相关的疾病的组合物与方法 | |
| EP1379261A4 (en) | METHOD FOR INCREASING THE SEROTONIN LEVELS OF A PERSON BY ADMINISTRATING A COMPOSITION WITH (-) - HYDROXYCITRONIC ACID, AND RELATED COMPOSITIONS | |
| CN103908567B (zh) | 一种用于治疗糖尿病痛性神经病变的复方制剂及其应用 | |
| JP2007008878A (ja) | 非運動性及び非急性ストレス性疲労の治療剤 | |
| JP7126172B2 (ja) | 肝の線維化を伴い得るｎａｆｌｄモデル動物、その作製方法、及びそれを作製するための飼料 | |
| WO2007021735A2 (en) | Use of phospholipid arachidonic acids for increasing muscle mass in humans | |
| KR102192586B1 (ko) | 아위버섯의 추출물 또는 분말을 유효성분으로 함유하는 지방간 질환 치료용 약학적 조성물 및 간기능 개선용 건강기능식품 | |
| WO2004006946A1 (en) | Composition comprising the crude extract of the fruit of morus alba l having neuro-protective activity | |
| JP5269297B2 (ja) | ニンニク成分を含有する高血圧の予防及び／又は治療用組成物 |